Leading social enterprise Turning Point has proudly announced that its Hammersmith and Fulham drug and substance use service has successfully achieved micro-elimination of Hepatitis C, marking a significant milestone in public health and community care.
The dedicated team at Hammersmith and Fulham focused on increasing testing, treatment initiation, and completion rates among the population it serves. Their efforts were guided by four key NHS targets:
- 100%of service users were offered a Hepatitis C test.
- 98% of individuals with a history of injecting drug use were tested.
- 90% of those individuals were tested within the last 12 months.
- 90% of diagnosed individuals began treatment.
This comprehensive strategy led to the service achieving micro-elimination, a term used when Hepatitis C transmission is effectively halted within a defined population.
Understanding Hepatitis C and Its Risks
Hepatitis C is a bloodborne virus that can cause serious liver damage over time, including cirrhosis, liver failure, and cancer. Globally, it accounts for approximately 290,000 deaths and 1.5 million new infections each year.
In the UK, injecting drug use remains the most significant risk factor for Hepatitis C transmission. That’s why substance use services play a vital role in prevention and early detection.
Accessible Testing Through Substance Use Services
Turning Point’s services offer free Dried Blood Spot Tests (DBST) — a simple and minimally invasive method to test for bloodborne viruses such as Hepatitis B, Hepatitis C, and HIV. These tests are crucial in identifying infections early and connecting individuals to life-saving treatment.
A Service User’s Experience: Clive’s Story
Clive (not his real name), who had previously undergone treatment for Hepatitis C, shared his positive experience with Turning Point:
‘I found the new treatment simpler, easier and shorter compared to the treatment I had a few years ago,’ said Clive.
‘I would recommend the treatment to anyone who is Hepatitis C positive. The nurses and the staff at Turning Point who supported me with the treatment were amazing.  I would really urge people to get tested for Hepatitis C as it’s so easy to do.’
Leadership Reflections on the Achievement
Neil Jones-Lumby, Senior Operations Manager at Turning Point’s Hammersmith and Fulham service, commented: ‘We are proud to announce that Hammersmith and Fulham has successfully reached micro-elimination. This is a testament to the hard work of the staff team and the relationships we have with our service users.  This success shows what is possible when we combine compassion, innovation and determination.’
Dawn Baker, Turning Point’s National Blood-Borne Viruses (BBVs) Lead, added: ‘I am extremely proud of the team’s efforts ensuring some of the country’s most vulnerable people easily access testing and treatment for Hepatitis C.  Collaborative and person-centred care has allowed us to achieve this target.’
A Model for Future Public Health Success
Turning Point’s achievement in Hammersmith and Fulham serves as a powerful example of what can be accomplished through community engagement, accessible healthcare, and compassionate support. It sets a precedent for other services aiming to eliminate Hepatitis C and improve health outcomes for vulnerable populations.
DDN magazine is a free publication self-funded through advertising.
We are proud to work in partnership with many of the leading charities and treatment providers in the sector.
This content was created by Turning Point